The CARI program and overcoming commercialization challenges in the Canadian isotope sector

Wednesday, June 23, 2021

11:00 a.m.

CARI is a collaboration between The Centre for Probe Development and Commercialization (CPDC) and adMare BioInnovations (adMare) working to bring respective resources together to advance an area of tremendous therapeutic and commercial potential in which Canada can gain considerable global competitive advantage in radiopharmaceuticals.

Join us for this event where we will learn how the CARI program is exploring opportunities arising from academic discoveries and early enterprises, establishing rigorous drug development programs around selected opportunities, and driving the generation of proof-of-principle for the commercialization of new radiopharmaceutical assets.

Dr. Bruno Paquin
Dr. Ghadeer Shubassi
Senior Business Development Manager
Yasamin Allahverdi
Business Analyst
Dr. Stuart Cain
Associate Director, Scientific Evaluation
adMare BioInnovations
Dr. Lana Janes
Venture Partner
adMare BioInnovations
Eric Cruz
Associate Scientist, Biologics
adMare BioInnovations
James Scongack
EVP, Bruce Power
Chair, Canadian Nuclear Isotope Council
Andrew Thiele
Director Strategic Initiatives
Canadian Nuclear Isotopes Council